# GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst

> **NCT04993924** · PHASE4 · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- IVF
- Ovarian Cysts

## Interventions

- **DRUG:** Cetrorelix Acetate, Ganerelix Acetate

## Key facts

- **NCT ID:** NCT04993924
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04993924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04993924, "GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04993924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*